United States · 
Who invested in BridGene Biosciences?
BridGene Biosciences's investors include Kaitai Capital.
United States · Series B startup
Who invested in BridGene Biosciences
Funding summaryUpdated 26 Oct 2026
$28Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $28MOct 2025
- Investors
- 1
The rounds
- Oct 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about BridGene Biosciences
How much has BridGene Biosciences raised?
BridGene Biosciences has raised $28M across 1 round since 2025.
When did BridGene Biosciences last raise?
BridGene Biosciences's most recent round was a Series B of $28M in Oct 2025.
What was BridGene Biosciences's biggest round?
Its most recent round, $28M in Oct 2025, is also its largest on record.
Who backed BridGene Biosciences first?
BridGene Biosciences's first round on record, in Oct 2025, was backed by Kaitai Capital.
What stage is BridGene Biosciences at?
BridGene Biosciences's latest named round is a Series B, in Oct 2025.
Where is BridGene Biosciences based?
BridGene Biosciences is based in the United States.
Companies like BridGene Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.